Actions of isoform-selective and non-selective nitric oxide synthase inhibitors on endotoxin-induced vascular leakage in rat colon

European Journal of Pharmacology

Volumn 334, Issue 1, 1997, Pages 99-102

  László, Ferenc ^a   Whittle, Brendan J R ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

endotoxin; Inducible nitric oxide (NO) synthase; Inflammation; Microcirculation; Nitric oxide (NO); Nitric oxide (NO) synthase inhibitors; Vascular permeability

Indexed keywords

AMINOGUANIDINE; ENDOTOXIN; ESCHERICHIA COLI ENDOTOXIN; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD PRESSURE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

AMIDINES; ANIMALS; BENZYLAMINES; CAPILLARY PERMEABILITY; COLON; ENDOTOXINS; ENZYME INHIBITORS; ESCHERICHIA COLI; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; ORNITHINE; RATS; RATS, WISTAR;

EID: 0342378148     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01163-1     Document Type: Article

References (11)

1. Boughton-Smith N.K., Evans S.M., László F., Whittle B.J.R., Moncada S. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br. J. Pharmacol. 110:1993;1189-1195.
2. Corbett J.A., Tilton R.A., Chang K., Hasan K.S., Ido Y., Wang J.L., Sweetland M., Lancester J.R., Williamson J.R., McDaniel M.L. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes. 41:1992;552-556.
3. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., László F., Whittle B.J.R., Knowles R.G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 21:1997;4959-4963.
4. Kubes P., Granger D.N. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262:1992;H611-H615.
5. Kubes P., Suzuki M., Granger D.N. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA. 88:1991;4651-4655.
6. László F., Whittle B.J.R., Moncada S. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br. J. Pharmacol. 111:1994;1309-1315.
7. László F., Evans S.M., Whittle B.J.R. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur. J. Pharmacol. 272:1995;169-175.
8. Lopez-Belmonte J., Whittle B.J.R. Aminoguanidine-provoked leukocyte adherence to rat mesenteric venules: Role of constitutive nitric oxide synthase inhibition. Br. J. Pharmacol. 116:1995;2710-2714.
9. Moncada S., Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9:1995;1319-1330.
10. Rees D.D., Palmer R.M.J., Shulz R., Moncada S. Characterisation of three inhibitors of endothelial nitric oxide in vitro and in vivo. Br. J. Pharmacol. 101:1990;746-752.
11. Tepperman B.L., Brown J.F., Korolkiewitz R., Whittle B.J.R. Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells. J. Pharmacol. Exp. Ther. 271:1994;1477-1482.